日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML.

BPR1J-097 是一种新型 FLT3 激酶抑制剂,对 AML 具有强大的抑制活性

Lin W-H, Jiaang W-T, Chen C-W, Yen K-J, Hsieh S-Y, Yen S-C, Chen C-P, Chang K-Y, Chang C-Y, Chang T-Y, Huang Y-L, Yeh T-K, Chao Y-S, Chen C-T, Hsu J T-A

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study

非细胞毒性苏拉明作为晚期非小细胞肺癌患者的化疗增敏剂:一项 II 期研究

Villalona-Calero, M A; Otterson, G A; Wientjes, M G; Weber, F; Bekaii-Saab, T; Young, D; Murgo, A J; Jensen, R; Yeh, T-K; Wei, Y; Zhang, Y; Eng, C; Grever, M; Au, J L-S